Dr. Camacho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
409 E Merced Ave Ste A
West Covina, CA 91790Phone+1 858-699-7726Fax+1 858-793-5640
Summary
- I am Board Certified in Pediatrics and Medical Biochemical Genetics.
I mostly do clinical work. My main interest are patients with disorders
of the Urea cycle, Lysosomal storage disease and Mitochondrial disease.
My main research accomplishment was the discovery and characterization
of three mitochondrial ornithine transporters, ORNT1, ORNT2 and ORNT3.
Human ORNT1 is the gene that is responsible for HHH syndrome (Hyperornithinemia, Hyperammonemia Homocitrullinuria syndrome).
Education & Training
- Johns Hopkins UniversityFellowship, Medical Biochemical Genetics, 1982 - 1983
- University of Missouri-ColumbiaResidency, Pediatrics, 1980 - 1983
- Universidad Central del Caribe School of MedicineClass of 1980
Certifications & Licensure
- NY State Medical License 1985 - 2026
- CA State Medical License 1994 - 2025
- MT State Medical License 2014 - 2016
- OK State Medical License 2000 - 2003
- MD State Medical License 1998 - 2000
- American Board of Medical Genetics and Genomics Medical Biochemical Genetics
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Postdoctoral Fellow Presentation 1998 American Society of Human Genetics Meeting Denver, Colorado ASHG, 1998
Clinical Trials
- Early Access Program With Arimoclomol in US Patients With NPC
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 147 citationsHyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter.Jose A. Camacho, Cassandra Obie, Barbara Biery, Barbara K. Goodman, Chien-An Andy Hu
Nature Genetics. 1999-06-01 - 7 citationsAdult-onset presentation of a hyperornithinemia-hyperammonemia-homocitrullinuria patient without prior history of neurological complications.Kamer Tezcan, Kristal T. Louie, Yong Qu, Jorge Velasquez, Frank Zaldivar
JIMD Reports. 2011-09-22 - 5 citationsIdentification of leading hazardous waste generating industries with high improvement potential in Spain.José A. Camacho, Soraya María Ruíz-Peñalver, Mercedes Rodríguez
The Science of the Total Environment. 2020-08-20
Journal Articles
- BICRA, a SWI/SNF Complex Member, Is Associated with BAF-Disorder Related Phenotypes in Humans and Model OrganismsScott Barish 1, Tahsin Stefan Barakat 2, Brittany C Michel 3, Nazar Mashtalir 3, Jennifer B Phillips 4, Alfredo M Valencia 5, Berrak Ugur 6, Jeremy Wegner 4, Tiana M S..., Am J Hum Genet . 2020 Dec 3;107(6):1096-1112, 12/3/2020
Authored Content
- Gene Reviews Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome Synonym: HHH SyndromeFebruary 2020
- Adult-onset presentation of a hyperornithinemia-hyperammonemia-homocitrullinuria patient without prior history of neurological complicationsJune 2012
- The human and mouse SLC25A29 mitochondrial transporters rescue the deficient ornithine metabolism in fibroblasts of patients with the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndromeJuly 2009
- Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndromeOctober 2006
- Cloning and characterization of human ORNT2: a second mitochondrial ornithine transporter that can rescue a defective ORNT1 in patients with the hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, a urea cycle disorderAugust 2003
- Identification and molecular analysis of the gene responsible for the Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome.June 1999
- Join now to see all
Grant Support
- Mechanisms of disease for the Human ORNT1 deficiencyRobert Wood Johnson Foundation Harold Amos Minority Faculty Award2004–2009
Research History
- Assistant Professor of Pediatrics UCI School of medicineWorked on characterizing additional mitochondrial ornithine transporters, ORNT2 (SLC25A2) and ORNT3 (SLC25A29) Described new ORNT1 mutations Worked on a MmOrnt1 KO model Characterized the MmOrnt2 gene2004 - 2013
Professional Memberships
- Member
Other Languages
- Spanish
Industry Relationships
- Speaker Bureau, Genzyme SanofiGives lectures about Fabry disease to affected families and Nieman Pick B to physiciansDisclosure: Get compensated per lecture (presentation)2019 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: